BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 13243272)

  • 1. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 5. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of heparin action by modification of its structure.
    Danishefsky I
    Fed Proc; 1977 Jan; 36(1):33-5. PubMed ID: 830555
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma antithrombins during heparin therapy.
    Boneu B; Sie P; Caranobe C; Guittard J
    Thromb Res; 1982 Jul; 27(1):123-4. PubMed ID: 7123511
    [No Abstract]   [Full Text] [Related]  

  • 12. INCREASE IN PLASMA ANTITHROMBIN ACTIVITY FOLLOWING TOTAL BODY EXPOSURE TO SMALL AND MEDIUM DOSES OF ROENTGEN RAYS IN DOGS.
    SVEHLA C; RYSANEK K; KOENIG J; SPANKOVA H; MLEJNKOVA M
    Blood; 1965 Apr; 25():622-5. PubMed ID: 14284346
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of heparin resistance and their clinical significance].
    Barkagan ZS; Lychev VG; Bishevskiĭ KM; Tsyvkina LP; Glazunova GA
    Ter Arkh; 1982; 54(8):77-82. PubMed ID: 6753220
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of heparin in current therapy of thrombotic disease].
    Komarnicki M
    Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat.
    Büller HR; Hobbelen PM; Princen AW; Moelker HC; ten Cate JW
    Thromb Res; 1983 Sep; 31(6):787-97. PubMed ID: 6196855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of heparin through thrombin on blood coagulation.
    Machovich R
    Biochim Biophys Acta; 1975 Nov; 412(1):13-7. PubMed ID: 1191673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.